Cargando…
Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients
Circulating cell-free DNA (cfDNA) has been investigated as a screening tool for many diseases. To avoid expensive and time-consuming DNA isolation, direct quantification PCR assays can be established. However, rigorous validation is required to provide reliable data in the clinical and non-clinical...
Autores principales: | Neuberger, Elmo W. I., Brahmer, Alexandra, Ehlert, Tobias, Kluge, Katrin, Philippi, Keito F. A., Boedecker, Simone C., Weinmann-Menke, Julia, Simon, Perikles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245561/ https://www.ncbi.nlm.nih.gov/pubmed/34193884 http://dx.doi.org/10.1038/s41598-021-92826-4 |
Ejemplares similares
-
Twelve-Week Internet-Based Individualized Exercise Program in Adults With Systemic Lupus Erythematosus: Protocol for a Randomized Controlled Trial
por: Boedecker, Simone Cosima, et al.
Publicado: (2020) -
Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study
por: Hoeter, Katharina, et al.
Publicado: (2023) -
Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy
por: Neuberger, Elmo W. I., et al.
Publicado: (2022) -
cfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infections in general practice: a study protocol for a prospective cohort study
por: Dehnen, Dorothea, et al.
Publicado: (2022) -
Microfluidic Technologies for cfDNA Isolation and Analysis
por: Xu, Zheyun, et al.
Publicado: (2019)